Tryptophan-hydroxylase 2 haplotype association with borderline personality disorder and aggression in a sample of patients with personality disorders and healthy controls

Journal of Psychiatric Research

Volumn 44, Issue 15, 2010, Pages 1075-1081

  Mercedes Perez Rodriguez, M M ^a   Weinstein, Shauna ^a,b   New, Antonia S ^a,b   Bevilacqua, Laura ^c   Yuan, Qiaoping ^c   Zhou, Zhifeng ^c   Hodgkinson, Colin ^c   Goodman, Marianne ^a,b   Koenigsberg, Harold W ^a,b   Goldman, David ^c   Siever, Larry J ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

Affective instability; Borderline personality disorder; Impulsive aggression; Suicidal behavior; TPH2

Indexed keywords

TRYPTOPHAN HYDROXYLASE 2;

ADULT; AFRICAN AMERICAN; AGGRESSION; ARTICLE; ASIAN; BORDERLINE STATE; CAUCASIAN; CONTROLLED STUDY; DEPRESSION; ETHNIC DIFFERENCE; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HAPLOTYPE; HISPANIC; HUMAN; IMPULSIVENESS; INDIAN; MAJOR CLINICAL STUDY; MALE; MENTAL INSTABILITY; PERSONALITY DISORDER; PREDICTION; PRIORITY JOURNAL; SCORING SYSTEM; SUICIDAL BEHAVIOR;

EID: 77958151312     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2010.03.014     Document Type: Article

References (78)

1. Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Archives of General Psychiatry 1961, 4:561-571.
2. Bernstein D.P., Stein J.A., Newcomb M.D., Walker E., Pogge D., Ahluvalia T., et al. Development and validation of a brief screening version of the childhood trauma questionnaire. Child Abuse & Neglect 2003, 27:169-190.
3. Buss A.H., Durkee A. An inventory for assessing different kinds of hostility. Journal of Consulting Psychology 1957, 21:343-349.
4. Buss A.H., Perry M. The aggression questionnaire. Journal of Personality and Social Psychology 1992, 63:452-459.
5. Clark A.G. The role of haplotypes in candidate gene studies. Genetic Epidemiology 2004, 27:321-333.
6. Coccaro E.F., Astill J.L. Central serotonergic function in parasuicide. Progress in Neuro-Psychopharmacology & Biological Psychiatry 1990, 14:663-674.
7. Coccaro E.F., Astill J.L., Herbert J.L., Schut A.G. Fluoxetine treatment of impulsive aggression in DSM-III-R personality disorder patients. Journal of Clinical Psychopharmacology 1990, 10:373-375.
8. Coccaro E.F., Berman M.E., Kavoussi R.J., Hauger R.L. Relationship of prolactin response to d-fenfluramine to behavioral and questionnaire assessments of aggression in personality-disordered men. Biological Psychiatry 1996, 40:157-164.
9. Coccaro E.F., Gabriel S., Siever L.J. Buspirone challenge: preliminary evidence for a role for central 5-HT1a receptor function in impulsive aggressive behavior in humans. Psychopharmacology Bulletin 1990, 26:393-405.
10. Coccaro E.F., Kavoussi R.J., Cooper T.B., Hauger R.L. Central serotonin activity and aggression: inverse relationship with prolactin response to d-fenfluramine, but not CSF 5-HIAA concentration, in human subjects. The American Journal of Psychiatry 1997, 154:1430-1435.
11. Coccaro E.F., Kavoussi R.J., Hauger R.L. Physiological responses to d-fenfluramine and ipsapirone challenge correlate with indices of aggression in males with personality disorder. International Clinical Psychopharmacology 1995, 10:177-179.
12. Coccaro E.F., Kavoussi R.J., Trestman R.L., Gabriel S.M., Cooper T.B., Siever L.J. Serotonin function in human subjects: intercorrelations among central 5-HT indices and aggressiveness. Psychiatry Research 1997, 73:1-14.
13. Coccaro E.F., Siever L.J., Klar H.M., Maurer G., Cochrane K., Cooper T.B., et al. Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior. Archives of General Psychiatry 1989, 46:587-599.
14. Coolidge F.L., Thede L.L., Jang K.L. Heritability of personality disorders in childhood: a preliminary investigation. Journal of Personality Disorders 2001, 15:33-40.
15. Coon H., Dunn D., Lainhart J., Miller J., Hamil C., Battaglia A., et al. Possible association between autism and variants in the brain-expressed tryptophan hydroxylase gene (TPH2). American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 2005, 135B:42-46.
16. Cornelius J.R., Soloff P.H., Perel J.M., Ulrich R.F. A preliminary trial of fluoxetine in refractory borderline patients. Journal of Clinical Psychopharmacology 1991, 11:116-120.
17. De Luca V., Mueller D.J., Tharmalingam S., King N., Kennedy J.L. Analysis of the novel TPH2 gene in bipolar disorder and suicidality. Molecular Psychiatry 2004, 9:896-897.
18. De Luca V., Voineskos D., Wong G.W., Shinkai T., Rothe C., Strauss J., et al. Promoter polymorphism of second tryptophan hydroxylase isoform (TPH2) in schizophrenia and suicidality. Psychiatry Research 2005, 134:195-198.
19. Endicott J., Spitzer R.L. A diagnostic interview: the schedule for affective disorders and schizophrenia. Archives of General Psychiatry 1978, 35:837-844.
20. First M., Spitzer R., Gibbon M., Williams J., Davies M., Borus J., et al. The structured clinical interview for DSM-III-R personality disorders (SCID-II). Part II: multi-site test-retest reliability study. Journal of Personality Disorders 1995, 9:92-104.
21. Goodman M., New A., Siever L. Trauma, genes, and the neurobiology of personality disorders. Annals of the New York Academy of Sciences 2004, 1032:104-116.
22. Goveas J.S., Csernansky J.G., Coccaro E.F. Platelet serotonin content correlates inversely with life history of aggression in personality-disordered subjects. Psychiatry Research 2004, 126:23-32.
23. Gurvits I.G., Koenigsberg H.W., Siever L.J. Neurotransmitter dysfunction in patients with borderline personality disorder. The Psychiatric Clinics of North America 2000, 23:27-40. vi.
24. Halperin J.M., Schulz K.P., McKay K.E., Sharma V., Newcorn J.H. Familial correlates of central serotonin function in children with disruptive behavior disorders. Psychiatry Research 2003, 119:205-216.
25. Harvey P.D., Greenberg B.R., Serper M.R. The affective lability scales: development, reliability, and validity. Journal of Clinical Psychology 1989, 45:786-793.
26. Hodgkinson C.A., Yuan Q., Xu K., Shen P.H., Heinz E., Lobos E.A., et al. Addictions biology: haplotype-based analysis for 130 candidate genes on a single array. Alcohol Alcoholism 2008, 43:505-515.
27. Ji W.Y., Hu Y.H., Huang Y.Q., Cao W.H., Lv J., Qin Y., et al. Zhonghua Liu Xing Bing Xue Za Zhi 2006, 27:137-141.
28. Kendler K.S., Aggen S.H., Czajkowski N., Roysamb E., Tambs K., Torgersen S., et al. The structure of genetic and environmental risk factors for DSM-IV personality disorders: a multivariate twin study. Archives of General Psychiatry 2008, 65:1438-1446.
29. Kulikov A.V., Osipova D.V., Naumenko V.S., Popova N.K. Association between Tph2 gene polymorphism, brain tryptophan hydroxylase activity and aggressiveness in mouse strains. Genes, Brain, and Behavior 2005, 4:482-485.
30. Leyton M., Okazawa H., Diksic M., Paris J., Rosa P., Mzengeza S., et al. Brain regional alpha-[11C]methyl-l-tryptophan trapping in impulsive subjects with borderline personality disorder. The American Journal of Psychiatry 2001, 158:775-782.
31. Lidberg L., Belfrage H., Bertilsson L., Evenden M.M., Asberg M. Suicide attempts and impulse control disorder are related to low cerebrospinal fluid 5-HIAA in mentally disordered violent offenders. Acta Psychiatrica Scandinavica 2000, 101:395-402.
32. Linehan M, Wagner A, Cox G. Parasuicide history interview: comprehensive assessment of parasuicidal behavior [unpublished manuscript]. Seattle: University of Washington, 1983.
33. Linnoila M., DeJong J., Virkkunen M. Family history of alcoholism in violent offenders and impulsive fire setters. Archives of General Psychiatry 1989, 46:613-616.
34. Linnoila M., Virkkunen M., George T., Eckardt M., Higley J.D., Nielsen D., et al. Serotonin, behavior and alcohol. Toward a molecular basis of alcohol use and abuse 1994, Birkhauser Verlag Base, Switzerland. B. Jansson, H. Jornvall, U. Rydberg, L. Terenius, L. Vallee (Eds.).
35. Lopez de Lara C., Brezo J., Rouleau G., Lesage A., Dumont M., Alda M., et al. Effect of tryptophan hydroxylase-2 gene variants on suicide risk in major depression. Biological Psychiatry 2007, 62:72-80.
36. Loranger A.W., Oldham J.M., Tulis E.H. Familial transmission of DSM-III borderline personality disorder. Archives of General Psychiatry 1982, 39:795-799.
37. Lyons-Ruth K., Holmes B.M., Sasvari-Szekely M., Ronai Z., Nemoda Z., Pauls D. Serotonin transporter polymorphism and borderline or antisocial traits among low-income young adults. Psychiatric Genetics 2007, 17:339-343.
38. Marsh D.M., Dougherty D.M., Moeller F.G., Swann A.C., Spiga R. Laboratory-measured aggressive behavior of women: acute tryptophan depletion and augmentation. Neuropsychopharmacology 2002, 26:660-671.
39. McGlashan T.H., Grilo C.M., Sanislow C.A., Ralevski E., Morey L.C., Gunderson J.G., et al. Two-year prevalence and stability of individual DSM-IV criteria for schizotypal, borderline, avoidant, and obsessive-compulsive personality disorders: toward a hybrid model of axis II disorders. The American Journal of Psychiatry 2005, 162:883-889.
40. Mossner R., Walitza S., Geller F., Scherag A., Gutknecht L., Jacob C., et al. Transmission disequilibrium of polymorphic variants in the tryptophan hydroxylase-2 gene in children and adolescents with obsessive-compulsive disorder. The International Journal of Neuropsychopharmacology 2006, 9:437-442.
41. New A.S., Buchsbaum M.S., Hazlett E.A., Goodman M., Koenigsberg H.W., Lo J., et al. Fluoxetine increases relative metabolic rate in prefrontal cortex in impulsive aggression. Psychopharmacology (Berlin) 2004, 176:451-458.
42. New A.S., Gelernter J., Yovell Y., Trestman R.L., Nielsen D.A., Silverman J., et al. Tryptophan hydroxylase genotype is associated with impulsive-aggression measures: a preliminary study. American Journal of Medical Genetics 1998, 81:13-17.
43. New A.S., Goodman M., Triebwasser J., Siever L.J. Recent advances in the biological study of personality disorders. The Psychiatric Clinics of North America 2008, 31:441-461. vii.
44. New A.S., Hazlett E.A., Buchsbaum M.S., Goodman M., Mitelman S.A., Newmark R., et al. Amygdala-prefrontal disconnection in borderline personality disorder. Neuropsychopharmacology 2007, 32:1629-1640.
45. New A.S., Trestman R.F., Mitropoulou V., Goodman M., Koenigsberg H.H., Silverman J., et al. Low prolactin response to fenfluramine in impulsive aggression. Journal of Psychiatric Research 2004, 38:223-230.
46. Ni X., Bismil R., Chan K., Sicard T., Bulgin N., McMain S., et al. Serotonin 2A receptor gene is associated with personality traits, but not to disorder, in patients with borderline personality disorder. Neuroscience Letters 2006, 408:214-219.
47. Ni X., Chan D., Chan K., McMain S., Kennedy J.L. Serotonin genes and gene-gene interactions in borderline personality disorder in a matched case-control study. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2008.
48. Ni X., Chan D., Chan K., McMain S., Kennedy J.L. Serotonin genes and gene-gene interactions in borderline personality disorder in a matched case-control study. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2009, 33:128-133.
49. Ni X., Chan K., Bulgin N., Sicard T., Bismil R., McMain S., et al. Association between serotonin transporter gene and borderline personality disorder. Journal of Psychiatric Research 2006, 40:448-453.
50. Ni X., Sicard T., Bulgin N., Bismil R., Chan K., McMain S., et al. Monoamine oxidase a gene is associated with borderline personality disorder. Psychiatry Research 2007, 17:153-157.
51. O'Keane V., Moloney E., O'Neill H., O'Connor A., Smith C., Dinan T.G. Blunted prolactin responses to d-fenfluramine in sociopathy. Evidence for subsensitivity of central serotonergic function. The British Journal of Psychiatry 1992, 160:643-646.
52. Oades R.D., Lasky-Su J., Christiansen H., Faraone S.V., Sonuga-Barke E.J., Banaschewski T., et al. The influence of serotonin- and other genes on impulsive behavioral aggression and cognitive impulsivity in children with attention-deficit/hyperactivity disorder (ADHD): findings from a family-based association test (FBAT) analysis. Behavioral and Brain Functions 2008, 4:48.
53. Oldham J.M. Borderline personality disorder and suicidality. The American Journal of Psychiatry 2006, 163:20-26.
54. Pally R. The neurobiology of borderline personality disorder: the synergy of " nature and nurture" Journal of Psychiatric Practice 2002, 8:133-142.
55. Paris J., Zweig-Frank H., Kin N.M., Schwartz G., Steiger H., Nair N.P. Neurobiological correlates of diagnosis and underlying traits in patients with borderline personality disorder compared with normal controls. Psychiatry Research 2004, 121:239-252.
56. ® Personality (SIDP-IV) 1997, American Psychiatric Publishing, Inc.
57. Reist C., Helmeste D., Albers L., Chhay H., Tang S.W. Serotonin indices and impulsivity in normal volunteers. Psychiatry Research 1996, 60:177-184.
58. Rinne T., van den Brink W., Wouters L., van Dyck R. SSRI treatment of borderline personality disorder: a randomized, placebo-controlled clinical trial for female patients with borderline personality disorder. The American Journal of Psychiatry 2002, 159:2048-2054.
59. Rousseva A., Henry C., van den Bulke D., Fournier G., Laplanche J.L., Leboyer M., et al. Antidepressant-induced mania, rapid cycling and the serotonin transporter gene polymorphism. The Pharmacogenomics Journal 2003, 3:101-104.
60. Roy A., Adinoff B., Linnoila M. Acting out hostility in normal volunteers: negative correlation with levels of 5-HIAA in cerebrospinal fluid. Psychiatry Research 1988, 24:187-194.
61. Sheehan K., Lowe N., Kirley A., Mullins C., Fitzgerald M., Gill M., et al. Tryptophan hydroxylase 2 (TPH2) gene variants associated with ADHD. Molecular Psychiatry 2005, 10:944-949.
62. Sher L., Oquendo M.A., Li S., Ellis S., Brodsky B.S., Malone K.M., et al. Prolactin response to fenfluramine administration in patients with unipolar and bipolar depression and healthy controls. Psychoneuroendocrinology 2003, 28:559-573.
63. Siever L.J. Neurobiology of aggression and violence. The American Journal of Psychiatry 2008, 165:429-442.
64. Siever L.J., Torgersen S., Gunderson J.G., Livesley W.J., Kendler K.S. The borderline diagnosis III: identifying endophenotypes for genetic studies. Biological Psychiatry 2002, 51:964-968.
65. Silverman J.M., Pinkham L., Horvath T.B., Coccaro E.F., Klar H., Schear S., et al. Affective and impulsive personality disorder traits in the relatives of patients with borderline personality disorder. The American Journal of Psychiatry 1991, 148:1378-1385.
66. Skodol A.E., Siever L.J., Livesley W.J., Gunderson J.G., Pfohl B., Widiger T.A. The borderline diagnosis II: biology, genetics, and clinical course. Biological Psychiatry 2002, 51:951-963.
67. Sorgi P., Ratey J., Knoedler D.W., Markert R.J., Reichman M. Rating aggression in the clinical setting. A retrospective adaptation of the Overt Aggression Scale: preliminary results. Journal of Neuropsychiatry and Clinical Neurosciences 1991, 3:S52-S56.
68. Stanley B., Molcho A., Stanley M., Winchel R., Gameroff M.J., Parsons B., et al. Association of aggressive behavior with altered serotonergic function in patients who are not suicidal. American Journal of Psychiatry 2000, 157:609-614.
69. Steiger H., Joober R., Israel M., Young S.N., Ng Ying Kin N.M., Gauvin L., et al. The 5HTTLPR polymorphism, psychopathologic symptoms, and platelet [3H-] paroxetine binding in bulimic syndromes. The International Journal of Eating Disorders 2005, 37:57-60.
70. Torgersen S., Lygren S., Oien P.A., Skre I., Onstad S., Edvardsen J., et al. A twin study of personality disorders. Comprehensive Psychiatry 2000, 41:416-425.
71. Virkkunen M., Rawlings R., Tokola R., Poland R.E., Guidotti A., Nemeroff C., et al. CSF biochemistries, glucose metabolism, and diurnal activity rhythms in alcoholic violent offenders, fire setters, and healthy volunteers. Archives of General Psychiatry 1994, 51:20-27.
72. Walitza S., Renner T.J., Dempfle A., Konrad K., Wewetzer C., Halbach A., et al. Transmission disequilibrium of polymorphic variants in the tryptophan hydroxylase-2 gene in attention-deficit/hyperactivity disorder. Molecular Psychiatry 2005, 10:1126-1132.
73. Walther D.J., Bader M. A unique central tryptophan hydroxylase isoform. Biochemical Pharmacology 2003, 66:1673-1680.
74. White C.N., Gunderson J.G., Zanarini M.C., Hudson J.I. Family studies of borderline personality disorder: a review. Harvard Review of Psychiatry 2003, 11:8-19.
75. Zaboli G., Gizatullin R., Nilsonne A., Wilczek A., Jonsson E.G., Ahnemark E., et al. Tryptophan hydroxylase-1 gene variants associate with a group of suicidal borderline women. Neuropsychopharmacology 2006, 31:1982-1990.
76. Zhou Z., Roy A., Lipsky R., Kuchipudi K., Zhu G., Taubman J., et al. Haplotype-based linkage of tryptophan hydroxylase 2 to suicide attempt, major depression, and cerebrospinal fluid 5-hydroxyindoleacetic acid in 4 populations. Archives of General Psychiatry 2005, 62:1109-1118.
77. Zill P., Baghai T.C., Zwanzger P., Schule C., Eser D., Rupprecht R., et al. SNP and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene provide evidence for association with major depression. Molecular Psychiatry 2004, 9:1030-1036.
78. Zill P., Buttner A., Eisenmenger W., Moller H.J., Bondy B., Ackenheil M. Single nucleotide polymorphism and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene in suicide victims. Biological Psychiatry 2004, 56:581-586.